OTC · RLFTY
Healthcare · Biotechnology
$0.18
Up+$0.00 (+0.00%)
Updated Nov 5, 2026, 4:53 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · RLFTY
1M range · 0 trading sessions · Daily adjusted prices
RLFTY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning RLFTY.
Company
Market Activity
Research & News
RLFTY research
Company profile and research snapshot.
RELIEF THERAPEUTICS S/ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 3, 2026 | BAADER EUROPE | Buy | — |
| Jun 16, 2026 | BAADER EUROPE | Buy | — |
| Jun 15, 2026 | BAADER EUROPE | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 14, 2026
Multi-site Program Demonstrates Threefold Increase in Rehabilitation Training Dose, With 84% Delivered Independently and Significant Improvements Across Functional Measures GENEVA, SWITZERLAND - October 14, 2026 (NEWMEDIAWIRE) - MindMaze Therapeu...
Yahoo · Oct 12, 2026
View presentations from European and Canadian public growth companies following the October 7–8 eventNEW YORK, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the third annual Global Markets Forum, held October 7–8, 2026, are now available for on-demand viewing. The event was presented in partnership with Aquis Stock Exchange, BME, Canadian Securities Exchange (CSE), OTC Markets Group, and
Yahoo · Oct 7, 2026
MindMaze Therapeutics CEO Zach Henderson joined Steve Darling from Proactive’s OTC studio in New York City to discuss the company’s digital neurotherapeutics platform, its approach to expanding rehabilitation access and its growth strategy in the United States and international markets. Henderson said MindMaze is addressing a growing gap between demand from patients recovering from stroke, spinal cord injury, traumatic brain injury and Parkinson’s disease and the limited availability of neurologists and physical therapists. The company’s platform uses gamified, high-dose and high-intensity training that combines physical and cognitive exercises. The technology can be used in inpatient rehabilitation facilities, outpatient centres and at home, giving patients more opportunities to train outside traditional therapy sessions. Henderson said asynchronous training is an important part of the model, helping overcome the limitations of a traditional one-patient, one-therapist approach. He noted that in various deployments, approximately 80% of training doses have been completed asynchronously, without a therapist present. MindMaze has also introduced an at-home model that can provide patients with a tablet and a small additional device. Therapists remain responsible for designing and overseeing programmes, while patients can complete additional training independently. Reimbursement and commercialisation are also key priorities for the company. Henderson said MindMaze already has two CPT codes in the United States and is pursuing payer coverage in additional markets. Studies underway in France and Switzerland are designed to support reimbursement efforts in those countries. The company is currently active in 13 countries, with Henderson identifying the United States as its largest growth opportunity. As MindMaze expands its commercial footprint, the company is focused on using digital technology to increase access to intensive neurorehabilitation while giving therapists tools to support more patients. #proactiveinvestors #mindmazetherapeutics #six #mmtx #otcqb #mmtzf #Neurorehabilitation #DigitalHealth #Neurotherapeutics #StrokeRecovery #Parkinsons #SpinalCordInjury #TraumaticBrainInjury #Rehabilitation #Healthcare #MedTech #HealthTech #DigitalTherapeutics #PhysicalTherapy #Neurology #USHealthcare #MedicalTechnology #Biotech #HealthcareInnovation
Yahoo · Oct 5, 2026
Two-day hybrid event will feature presentations from European and Canadian public growth companies, executive insights, and one-on-one investor meetingsNEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the third annual Global Markets Forum, taking place October 7–8, 2026, in partnership with Aquis Stock Exchange, BME, Canadian Securities Exchange (CSE), OTC Markets Group, and SIX Swiss Exch
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning RLFTY.
No results
No recent SID articles mention RLFTY.
